Transcutaneous Auricular Vagus Nerve Stimulation for Persistent Post-concussion Symptoms
Recruiting
N/A
Interventional Study
Persistent Post-concussive Symptoms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- University of Liege · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Persistent post-concussive symptoms (PPCS) affect a significant proportion of individuals following a concussion, leading to debilitating impacts on their quality of life and work capacity. Currently, effective treatments for PPCS are limited, despite their lasting and debilitating impact. Transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique, holds pro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age between 18 and 65;
* Between 4 weeks and 1-year post-diagnosis of a concussion;
* Score equal or above 16 on the Rivermead Post-Concussion Questionnaire;
* Intact skin at the electrode site.
Exclusion Criteria:
* History of chronic neurological or psychological disorders…
Contacts